UK's Boeringher Ingelheim, the ethical pharmaceutical manufacturer, has reinstated Schroder Investment Management to handle its £80m defined benefit scheme.
SIM fought off stiff competition from four other candidates. A review was initiated last June following concerns over manager performance and also because the scheme had been closed since the en...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here